Clinical Trial Update: Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin. [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating VMX-C001 versus usual pharmacological care in patients taking a Factor Xa direct oral anticoagulant who require urgent surgery, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding Disorders
• Coagulation Disorders

Drugs mentioned

• VMX-C001 (VMX-C001)

Snippet

Sponsor: VarmX B.V. | Conditions: Blood Loss, Surgical, Coagulation Disorder | Phase 3 | Status: NOT_YET_RECRUITING